ProfileGDS4718 / 213285_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 97% 98% 74% 98% 98% 89% 90% 98% 98% 97% 98% 97% 96% 89% 92% 98% 98% 93% 89% 66% 98% 98% 98% 97% 97% 94% 98% 72% 98% 92% 95% 87% 99% 98% 93% 90% 95% 98% 98% 40% 98% 92% 92% 89% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]11.122797
GSM549102patient 115, normal, homogenized [OPG study]11.434398
GSM549104patient 119, normal, homogenized [OPG study]7.2656374
GSM549108patient 138, normal, homogenized [OPG study]11.224198
GSM549119patient 077, normal, homogenized [OPG study]11.319598
GSM549133patient 032, cancer, homogenized [OPG study]9.1420489
GSM549139patient 042, cancer, homogenized [OPG study]9.1748390
GSM549099patient 107, normal, homogenized [OPG study]11.382698
GSM549109patient 139, normal, homogenized [OPG study]11.319598
GSM549110patient 046, normal, homogenized [OPG study]11.299497
GSM549114patient 063, normal, homogenized [OPG study]11.566598
GSM549122patient 082, normal, homogenized [OPG study]11.16997
GSM549134patient 033, cancer, homogenized [OPG study]10.580796
GSM549136patient 036, cancer, homogenized [OPG study]9.1105889
GSM549140patient 044, cancer, homogenized [OPG study]9.5323292
GSM549111patient 047, normal, homogenized [OPG study]11.570998
GSM549113patient 057, normal, homogenized [OPG study]11.527198
GSM549132patient 031, cancer, homogenized [OPG study]9.7024393
GSM549137patient 038, cancer, homogenized [OPG study]9.0620589
GSM549142patient 047, cancer, homogenized [OPG study]6.5621466
GSM549100patient 110, normal, homogenized [OPG study]11.250998
GSM549107patient 135, normal, homogenized [OPG study]11.560998
GSM549115patient 068, normal, homogenized [OPG study]11.534998
GSM549116patient 072, normal, homogenized [OPG study]11.218597
GSM549120patient 078, normal, homogenized [OPG study]11.089997
GSM549131patient 030, cancer, homogenized [OPG study]9.9618694
GSM549118patient 074, normal, homogenized [OPG study]11.454298
GSM549129patient 027, cancer, homogenized [OPG study]7.1171972
GSM549123patient 088, normal, homogenized [OPG study]11.530198
GSM549124patient 006, cancer, homogenized [OPG study]9.3459292
GSM549126patient 015, cancer, homogenized [OPG study]10.101295
GSM549128patient 025, cancer, homogenized [OPG study]8.7069387
GSM549103patient 117, normal, homogenized [OPG study]11.953799
GSM549117patient 073, normal, homogenized [OPG study]11.58298
GSM549138patient 041, cancer, homogenized [OPG study]9.7302593
GSM549141patient 045, cancer, homogenized [OPG study]9.3268290
GSM549130patient 028, cancer, homogenized [OPG study]10.072795
GSM549101patient 111, normal, homogenized [OPG study]11.240898
GSM549105patient 128, normal, homogenized [OPG study]11.649498
GSM549106patient 134, normal, homogenized [OPG study]4.9320540
GSM549112patient 048, normal, homogenized [OPG study]11.357898
GSM549125patient 011, cancer, homogenized [OPG study]9.4699792
GSM549127patient 024, cancer, homogenized [OPG study]9.525692
GSM549135patient 035, cancer, homogenized [OPG study]9.1834989